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Acute exacerbations of cystic fibrosis (CF) can be associated with dehydration, hyponatraemia and hypochloraemia. The syndrome of
inappropriate anti-diuretic hormone secretion (SIADH) has also been described in CF patients in the setting of hyponatraemia, but may be under-
recognised. Diagnosing SIADH has therapeutic implications as it necessitates fluid and water restriction rather than fluid resuscitation. We report
the case of an acute pulmonary exacerbation of CF in which features of SIADH are demonstrated.
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Dehydration with concurrent electrolyte depletion are well
described in the paediatric CF population, particularly in asso-
ciation with precipitating factors such as a pulmonary exacerba-
tion [1,2]. Treatment includes fluid and electrolyte replacement.
Associations have been described between SIADH and a
number of respiratory conditions. In SIADH, inappropriately high
levels of ADH interfere with urinary dilution and prevent the
excretion of ingested water, thereby causing hyponatraemia [3].
Treatment in this situation involves fluid and water restriction. A
subsequent clinical response supports the diagnosis.
We describe the case of a 25-year-old male with CF presenting
with an acute pulmonary exacerbation, and demonstrating
features of SIADH. Treatment with both free water restriction
and gentle fluid resuscitation resulted in resolution of the
hyponatraemia.⁎ Corresponding author. 9 Hilltop Crescent, East Ivanhoe, Victoria 3079,
Australia. Tel.:+61 403260064.
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We present a 25-year-old male with CF complicated by severe
obstructive lung disease with baseline forced expiratory volume
in 1 s (FEV1) of 16% predicted, pancreatic insufficiency with
malnutrition requiring nocturnal percutaneous endoscopic gastro-
stomy (PEG) feeding (body mass index of 14.5 kg/m2), gastro-
oesophageal reflux disease and osteopaenia. He had multiple and
increasingly prolonged inpatient admissions complicated by
respiratory failure, requiring treatment with intravenous anti-
biotics and bi-level, non-invasive, positive-pressure ventilation.
In November 2007, he was transferred to our service for
treatment of a pulmonary exacerbation and worsening hypercap-
nic respiratory failure, with an increase in PaCO2 from 55 mmHg
(baseline) to 71 mmHg. Medications at admission were
salmeterol, fluticasone, salbutamol, dornase alfa, co-trimoxazole,
nizatidine, mirtazapine, pancreatic enzyme supplementation,
magnesium aspartate, calcium carbonate and salt tablets. He
had been commenced on intravenous ceftazidime and gentamicin
prior to transfer to our hospital and recent culture results
demonstrated Pseudomonas aeruginosa (mucoid strain) sensitive
to ceftazidime and tobramycin. Past sputum cultures results had.V. on behalf of European Cystic Fibrosis Society. All rights reserved.
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cepacia complex.
On admission, serum sodium was 123 mmol/L with serum
chloride 74 mmol/L and total osmolality 256 mmol/kg.
Corresponding urinary parameters were chloride 94 mmol/L,
sodium 96 mmol/L and osmolality 425 mmol/kg (Table 1). On
examination, his weight was 46.2 kg, which represented an
acute fall of 1.7 kg compared to most recent measurements,
suggestive of volume depletion. Studies of thyroid and adrenal
function were normal. He had had no recent treatment with
diuretics. At this time, he was receiving 1 L of 0.9% saline
intravenously with no oral fluid restriction. Target volumes for
PEG feeds were 1 to 1.5 L per day, although these targets were
not always tolerated. This inappropriately high urine osmolality
in the presence of hyponatraemia was taken to confirm the
diagnosis of SIADH. Electrolyte depletion was also considered
a contributor to the hyponatraemia.
In light of this diagnosis of SIADH, treatment from day 2
was cessation of intravenous fluids and restriction of oral fluids
to 1 L per day. A small response in serum sodium and urinary
osmolality was seen with serum sodium increasing to
124 mmol/L and urinary osmolality falling to 377 mmol/kg.
On day 6, 1 L of 0.9% saline per day was recommenced
intravenously to supplement electrolytes and avoid dehydration.
To target the SIADH, oral fluid was restricted to 750 mL per day
including free water restriction. Serum sodium gradually
normalised, returning to 135 mmol/L by day 14 and remaining
constant at this level to day 80 and beyond. The patient's weight
increased gradually from 45.8 kg to 49 kg.
Metoclopramide, used for symptoms of abdominal bloating,
was replaced with ondansetron, but other regular medicationsTable 1
Parameter (normal rangea) Presentation Day 5 to 6 Convalescence
(day 80)
Serum
Sodium (135–143 mmol/L) 123 124 136
Osmolality (275–300 mmol/kg) 256 – 285
Chloride (99–107 mmol/L) 76 75 93
Potassium (3.5–5.0 mmol/L) 4.7 4.8 4.1
Glucose (4.0–6.0 mmol/L) 7.4 – 8.4
Urea (4.0–9.0 mmol/L) 1.9 2.2 1.9
TSH (0.3–5.0 mU/L) – 3.76 4.51
9 a.m. cortisol (100–540 nmol/L) 334 – 313
Urine
Sodium (mmol/L) 96 85 100
Osmolality (50–1200 mmol/kg) 425 377 443
Chloride (mmol/L) 94 62 115
Weight (kg) 46.2 45.8 49
Therapy
IV fluid 1 L 1 L No
Continuous PEG feeds achieved
with Nutrison Concentrate®
800 mL at
80 mL/h
960 mL at
80 mL/h
600 mL at
75 mL/h
Additional PEG bolus feeds
with Resource® 2.0
200 mL 200 mL 400 mL
Oral fluid restriction No 750 mL No
Free water restriction No Yes No
aNormal ranges as per the Alfred Hospital, Melbourne, Australia.were continued. Re-institution of the metoclopramide and relax-
ation of the fluid restriction after restoration of normal sodium
concentration did not lead to recurrence of hyponatraemia.
After a prolonged admission for intensive nutritional sup-
port, physiotherapy, increased use of non-invasive ventilation
and antibiotic therapy, serum electrolytes and osmolality nor-
malised despite an increase in urine osmolality. This suggested
correction of fluid and electrolyte deficits normalised the serum
sodium despite persistent features of the SIADH.
The patient also described subjective improvement in respi-
ratory status over this period of more aggressive treatment and
fluid restriction, but did not report any increased difficulty
clearing secretions.
3. Discussion
The patient presented had hyponatraemia in the setting of both
electrolyte depletion and SIADH. The findings of decreased
serum sodium and osmolality with inappropriately high urinary
osmolality were consistent with SIADH. This was supported by
an initial small response in these parameters to fluid and freewater
restriction. However, serum sodium eventually normalised over a
longer period of time with fluid and electrolyte replacement with
normal saline. This occurred despite the persistence of SIADH as
evidenced by elevated urinary osmolality.
Hyponatraemia, hypochloraemia and dehydration are well
recognised in CF patients and these electrolyte abnormalities may
be the presenting feature in these patients [4]. The abnormalities
are multifactorial in origin, being explained by a combination
of sweat losses together with gastrointestinal and respiratory
illness [5,6]. While this phenomenon is best described in
younger patients, more limited data indicate that it also occurs
in adults [7].
This example of SIADH in a patient with CF is the third such
reported case in the literature. The others were reported over
30 years ago, also in the context of acute exacerbations of late-
stage pulmonary disease [8]. Several other respiratory conditions
are known to cause SIADH, including pulmonary infections,
asthma, use of positive-pressure ventilation, small cell lung
carcinoma and mesothelioma [9]. While these disorders may co-
exist in an individual presenting with an exacerbation of CF, the
urinary findings in SIADH are the converse of what is typically
found in exacerbations of CF. The presence of SIADH can
be investigated by performing concurrent serum and urinary
osmolality, with the latter being elevated disproportionately.
These are relatively simple, inexpensive tests which can be per-
formed by most laboratories.
This case of hypovolaemic hypoelectrolytaemia and SIADH
in the setting of an acute respiratory exacerbation of CF
stresses the importance of considering differential diagnoses for
hyponatraemia. Low serum sodium in CF may be a direct effect
of electrolyte depletion or a dilutional effect with free water
retention in SIADH. In our case, positive-pressure ventilation
and bacterial lung infection were co-existing conditions that are
known to cause SIADH. The distinction is important clinically
as fluid resuscitation may need to be combined with free water
restriction.
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SIADH may be an under-recognised condition in patients
presenting with acute exacerbations of CF pulmonary disease.
Recognition of this process would necessitate a therapeutic
approach involving fluid restriction rather than fluid resuscitation.
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